4th Quarter - Termination
MERCURY PUBLIC AFFAIRS, LLC for KYTHERA BIOPHARMACEUTICALS, INC
Income
$40,000
Expenses
—
Terminated
Dec 31, 2013
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Pharmaceutical compounding. S. 959, Pharmaceutical Quality, Security, and Accountability Act; H. R. 3204, Drug Quality and Security Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALAN ELIAS | — |
| ED KUTLER | — |
| ERICK C. MULLEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.